On January 9, 2003, Rist, Oystein; Hogberg, Thomas; Holst Lange, Birgitte; Schwartz, Thue W.; Elling, Christian E. published a patent.Computed Properties of 75449-26-2 The title of the patent was Use of metal ion chelates in validating biological molecules as drug targets in test animal models. And the patent contained the following:
The invention discloses the use of chem. compounds or selections of chem. compounds (libraries) of the general Formula R1XFY(R1)GZR1 [F, G = N, O, S, Se, P; X, Y, Z = (un)branched C1-12 alkyl, aryl, heteroaryl, etc.; R1 = ABC; A = coupling or connecting moiety; B = spacer moiety; C = functional group] for in vivo methods for testing or validating the physiol. importance and/or the therapeutic or pharmacol. potential of biol. target mols., notably proteins such as, e.g., receptors and especially 7TM receptors in test animals expressing the biol. target mol. with, notably, a silent, engineered metal ion site. Use of specific metal ion binding sites of a generic nature in specific biol. target mols. such as, e.g. transmembrane proteins wherein the metal ion binding site is capable of forming a complex with a metal ion is also described. Also disclosed are chem. compounds or libraries suitable for use in methods for improving the in vivo pharmacokinetic behavior of metal ion chelates (e.g. the absorption pattern, the plasma half-life, the distribution, the metabolism and/or the elimination of the metal ion chelates). In order to improve the efficacy of the impact of the metal ion chelate on the biol. target mol. after administration of the metal ion chelate in vivo to a test animal, it is advantageous e.g. to increase the period during which the metal ion chelate is in the circulatory system and/or localized at the target. Further disclosed are metal ion-chelating compounds designed to be suitable for use in a target validation process according to the invention, as well as libraries of at least two or more of such metal ion-chelating compounds The experimental process involved the reaction of [2,2′-Bipyridine]-3,3′-diamine(cas: 75449-26-2).Computed Properties of 75449-26-2
The Article related to metal chelate drug screening target validation, protein target drug screening metal chelate, receptor target drug screening metal chelate, pharmacokinetics metal chelate drug screening and other aspects.Computed Properties of 75449-26-2